Coronary Artery Disease Clinical Trials

48 studies are recruiting for coronary artery disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

  1. Progress Bifurcation Global Registry

    Coronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions remain some of the mo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
    Run by
    Minneapolis Heart Institute Foundation
  2. Hybrid Group Singing

    The overall objective of the planned future clinical trial is to test the investigator's central hypothesis that habitual singing over several weeks, similar to habitual exercise, will lead to sustained and favorable vascular adaptation, thereby lowering cardiovascular disease (CVD) risk. The overa…

    Stage
    Not phased
    Ages
    55 to 89
    Site
    Medical College of Wisconsin, Milwaukee, Wisconsin
    Run by
    Medical College of Wisconsin
  3. Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

    Traditionally, the severity of a blockage (stenosis) in a coronary artery has been determined by visual angiographic assessment of the diameter of the artery at the level of a blockage compared to a normal healthy area of the same artery. With the advent of invasive physiological testing to assess …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Run by
    Beth Israel Deaconess Medical Center
  4. PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]

    Early detection of coronary atherosclerotic disease facilitates adequate prevention. The purpose of this study is to compare an assessment of coronary atherosclerotic disease burden by positron emission tomography / computed tomography (NaF-PET/CT) with those of conventional and ultra-high-resoluti…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Johns Hopkins Hospital, Baltimore, Maryland
    Run by
    Johns Hopkins University
  5. Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

    Dual antiplatelet therapy (DAPT) with low-dose aspirin and a P2Y12 inhibitor is the current standard of care in patients with coronary artery disease experiencing an acute event or undergoing percutaneous coronary intervention. However, the ischemic benefits are counterbalanced by a significant inc…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Florida, Jacksonville, Florida
    Run by
    University of Florida
  6. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

    Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama
    Locations
    9 in total
    Run by
    VA Office of Research and Development
  7. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

    The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    146 in total
    Run by
    Weill Medical College of Cornell University
  8. Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health

    The goal of this clinical trial is to evaluate whether disclosure of a polygenic risk score for coronary artery disease (CAD PRS) influences cardiovascular health and risk factor modification over one year among adults aged 30-75 years in the Mass General Brigham primary care network who are not cu…

    Stage
    Not phased
    Ages
    30 to 75
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Massachusetts General Hospital
  9. Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events

    The study aims to support patients immediately after percutaneous coronary intervention (PCI) by implementing a telemonitoring program. Eligible patients have coronary heart disease and undergo PCI. The intervention group receives remote monitoring and text-based follow-up, with established health …

    Stage
    Not phased
    Ages
    Any age
    Site
    University of California, Davis Medical Center Division of Cardiovascular Medicine, Sacramento, California
    Run by
    University of California, Davis
  10. Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

    The proposed study aims to assess the antiplatelet effects of more potent oral P2Y12 inhibition with low-dose ticagrelor (60 mg bid) compared with standard of care clopidogrel in patients with a high ABCD-GENE score (≥10). We hypothesize that ticagrelor is associated with better pharmacodynamic eff…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Florida Jacksonville, Jacksonville, Florida
    Run by
    University of Florida
  11. Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

    Ticagrelor currently represents the most tested and commonly used P2Y12 inhibitor monotherapy following percutaneous coronary intervention. The purpose of this study is to conduct a head-to-head comparison on the pharmacodynamic efficacy of ticagrelor-based and prasugrel-based single antiplatelet t…

    Stage
    Phase 4
    Ages
    18 to 75
    Site
    University of Florida Jacksonville, Jacksonville, Florida
    Run by
    University of Florida
  12. Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

    Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of r…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Tennessee Health Science Center/Regional One Health, Memphis, Tennessee
    Locations
    2 in total
    Run by
    University of Tennessee
  13. AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention

    AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intel…

    Stage
    Not phased
    Ages
    40 to 75
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Run by
    Brigham and Women's Hospital
  14. A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction

    Despite the relative safety of PCI with new generation stents, peri-PCI thrombotic complications, including myocardial infarction and myocardial injury, are common in elective PCI, occurring in up to 30% of patients. Importantly, these events are associated with poor prognosis. The risk of peri-PCI…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Florida Jacksonville, Jacksonville, Florida
    Run by
    University of Florida
  15. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

    This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Clearwater Cardiovascular and Interventional Consultants, Clearwater, Florida
    Locations
    24 in total
    Run by
    Concept Medical Inc.
  16. South Asians and Coronary Plaque Registry

    Individuals who self-report as SAs will be recruited to participate in this registry as well as non-SA controls for comparison. All individuals who consent to participate will 1) complete a survey assessing demographics, medical history, family medical history; 2) have blood collection; 3) and CCTA…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Texas Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  17. Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery

    Heart disease is the leading cause of death globally, accounting for 16% of the world's total deaths. The number of cases is expected to increase as our population ages. Heart disease also results in large economic burden. It costs the United States about $219 billion per year. Some patients have s…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University of Iowa Hospitals and Clinics, Iowa City, Iowa
    Run by
    University of Iowa
  18. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

    Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

    Stage
    Not phased
    Ages
    Any age
    Site
    Huntsville Heart Center, Huntsville, Alabama
    Locations
    72 in total
    Run by
    University of British Columbia
  19. PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

    This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Dignity Health - Chandler Regional Medical Center, Chandler, Arizona
    Locations
    18 in total
    Run by
    Kardion Inc
  20. Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure

    The clinical and demographic characteristics of patients undergoing transcatheter aortic valve implantation (TAVI) pose unique challenges for coronary computed tomography (CT) imaging, as this patient population is mainly composed of elderly, frail individuals with severe aortic stenosis, multiple …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Medical University of South Carolina, Charleston, South Carolina
    Locations
    7 in total
    Run by
    Semmelweis University
  21. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

    Stage
    Not phased
    Ages
    18 to 110
    Site
    Cardiology, PC - Princeton Baptist Medical Center, Birmingham, Alabama
    Locations
    28 in total
    Run by
    Concept Medical Inc.
  22. PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG

    To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.

    Stage
    Not phased
    Ages
    40 and older
    Site
    Metabolic Research Institute, Inc, West Palm Beach, Florida
    Run by
    Aventusoft, LLC.
  23. Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.

    Information gathered from the patients via a disease specific questionnaire will be married to data from the National Cardiovascular Data Registry (NCDR®). Details will be continuously analyzed and used to direct quality of care at our center. The institution is categorized as a low-volume institut…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Valley View Hospital, Glenwood Springs, Colorado
    Run by
    Cardiovascular Innovation and Research Institute

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.